Home
Leadiant Biosciences, Inc

Leadiant Biosciences, Inc Market Share Analysis for May 2026

Meet Ashley, a young woman living with ADA-SCID, a rare, inherited disorder that damages the immune system.

Health > Biotechnology and Pharmaceuticals

Domainleadiant.com

Year Founded1957

Employees51 - 200

Annual Revenue$15M - $25M

Leadiant Biosciences, Inc

Leadiant Biosciences, Inc (including company regionals)

leadiant.com

See more website traffic and engagement information

Leadiant Biosciences, Inc Revenue up to May 2026 is 15M - 25M

revenue generated by Leadiant Biosciences, Inc top domains

Leadiant Biosciences, Inc top domains revenue over 3 years

Revenue for Leadiant Biosciences, Inc top domains

leadiant.com15M - 25M

See more with Sales Intelligence

Total visits to Leadiant Biosciences, Inc's top domains

Understand Leadiant Biosciences, Inc market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

leadiant.com4K

See more with Sales Intelligence

Avg. visit duration in Leadiant Biosciences, Inc's top domains

Analyze Leadiant Biosciences, Inc engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

leadiant.com00:00:42

See more with Sales Intelligence

Avg. pageviews on Leadiant Biosciences, Inc's top domains

See how Leadiant Biosciences, Inc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

leadiant.com2.29

See more with Sales Intelligence

Leadiant Biosciences, Inc top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Leadiant Biosciences, Inc

These are the website technologies, by industry, used by Leadiant Biosciences, Inc top domains

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

9

See all

News & Signals from Leadiant Biosciences, Inc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLeadiant Biosciences Limited launches patient registry study.Leadiant Biosciences is proud to announce the introduction of a patient registry study that will provide supplemental information extended across a larger number of affected individuals.

NewsLeadiant Biosciences Limited launched largest patient savings program on Jun 28th '16.Now, Sigma-Tau Pharmaceuticals, the distributor of the VSL#3 brand, is launching its largest patient savings program in the history of the brand.

NewsLeadiant Biosciences Limited launched CYSTARAN on Apr 28th '13.Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau), a part of the Sigma-Tau Group Rare Disease Franchise, announced today the availability of CYSTARAN ™ (cysteamine ophthalmic solution) 0.44%, the first and only FDA-approved therapy for the treatment of corneal cystine crystal accumulation in patients with cystinosis.